Skip to main content
Top
Published in: Virology Journal 1/2008

Open Access 01-12-2008 | Research

Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences

Authors: Nobubelo K Ngandu, Konrad Scheffler, Penny Moore, Zenda Woodman, Darren Martin, Cathal Seoighe

Published in: Virology Journal | Issue 1/2008

Login to get access

Abstract

Background

Positive selection pressure acting on protein-coding sequences is usually inferred when the rate of nonsynonymous substitution is greater than the synonymous rate. However, purifying selection acting directly on the nucleotide sequence can lower the synonymous substitution rate. This could result in false inference of positive selection because when synonymous changes at some sites are under purifying selection, the average synonymous rate is an underestimate of the neutral rate of evolution. Even though HIV-1 coding sequences contain a number of regions that function at the nucleotide level, and are thus likely to be affected by purifying selection, studies of positive selection assume that synonymous substitutions can be used to estimate the neutral rate of evolution.

Results

We modelled site-to-site variation in the synonymous substitution rate across coding regions of the HIV-1 genome. Synonymous substitution rates were found to vary significantly within and between genes. Surprisingly, regions of the genome that encode proteins in more than one frame had significantly higher synonymous substitution rates than regions coding in a single frame. We found evidence of strong purifying selection pressure affecting synonymous mutations in fourteen regions with known functions. These included an exonic splicing enhancer, the rev-responsive element, the poly-purine tract and a transcription factor binding site. A further five highly conserved regions were located within known functional domains. We also found four conserved regions located in env and vpu which have not been characterized previously.

Conclusion

We provide the coordinates of genomic regions with markedly lower synonymous substitution rates, which are putatively under the influence of strong purifying selection pressure at the nucleotide level as well as regions encoding proteins in more than one frame. These regions should be excluded from studies of positive selection acting on HIV-1 coding regions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Muse SV, Gaut BS: A likelihood approach for comparing synonymous and nonsynonymous nucleotide substitution rates, with application to the chloroplast genome. Mol Biol Evol 1994, 11: 715-724.PubMed Muse SV, Gaut BS: A likelihood approach for comparing synonymous and nonsynonymous nucleotide substitution rates, with application to the chloroplast genome. Mol Biol Evol 1994, 11: 715-724.PubMed
2.
go back to reference Goldman N, Yang Z: A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol 1994, 11: 725-736.PubMed Goldman N, Yang Z: A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol 1994, 11: 725-736.PubMed
3.
go back to reference Nielsen R, Yang Z: Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 1998, 148: 929-936.PubMedCentralPubMed Nielsen R, Yang Z: Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 1998, 148: 929-936.PubMedCentralPubMed
4.
go back to reference Yang Z, Nielsen R, Goldman N, Pedersen AM: Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 2000, 155: 431-449.PubMedCentralPubMed Yang Z, Nielsen R, Goldman N, Pedersen AM: Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 2000, 155: 431-449.PubMedCentralPubMed
5.
go back to reference Lemey P, Kosakovsky Pond SL, Drummond AJ, Pybus OG, Shapiro B, Barroso H, Taveira N, Rambaut A: Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol 2007, 3: e29. 10.1371/journal.pcbi.0030029PubMedCentralCrossRefPubMed Lemey P, Kosakovsky Pond SL, Drummond AJ, Pybus OG, Shapiro B, Barroso H, Taveira N, Rambaut A: Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol 2007, 3: e29. 10.1371/journal.pcbi.0030029PubMedCentralCrossRefPubMed
6.
go back to reference Seoighe C, Ketwaroo F, Pillay V, Scheffler K, Wood N, Duffet R, Zvelebil M, Martinson N, McIntyre J, Morris L, Hide W: A model of directional selection applied to the evolution of drug resistance in HIV-1. Mol Biol Evol 2007, 24: 1025-1031. 10.1093/molbev/msm021CrossRefPubMed Seoighe C, Ketwaroo F, Pillay V, Scheffler K, Wood N, Duffet R, Zvelebil M, Martinson N, McIntyre J, Morris L, Hide W: A model of directional selection applied to the evolution of drug resistance in HIV-1. Mol Biol Evol 2007, 24: 1025-1031. 10.1093/molbev/msm021CrossRefPubMed
7.
go back to reference Choisy M, Woelk CH, Guegan JF, Robertson DL: Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J Virol 2004, 78: 1962-1970. 10.1128/JVI.78.4.1962-1970.2004PubMedCentralCrossRefPubMed Choisy M, Woelk CH, Guegan JF, Robertson DL: Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J Virol 2004, 78: 1962-1970. 10.1128/JVI.78.4.1962-1970.2004PubMedCentralCrossRefPubMed
8.
go back to reference de Oliveira T, Salemi M, Gordon M, Vandamme AM, van Rensburg EJ, Engelbrecht S, Coovadia HM, Cassol S: Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design? Genetics 2004, 167: 1047-1058. 10.1534/genetics.103.018135PubMedCentralCrossRefPubMed de Oliveira T, Salemi M, Gordon M, Vandamme AM, van Rensburg EJ, Engelbrecht S, Coovadia HM, Cassol S: Mapping sites of positive selection and amino acid diversification in the HIV genome: an alternative approach to vaccine design? Genetics 2004, 167: 1047-1058. 10.1534/genetics.103.018135PubMedCentralCrossRefPubMed
9.
go back to reference Zanotto PM, Kallas EG, de Souza RF, Holmes EC: Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 1999, 153: 1077-1089.PubMedCentralPubMed Zanotto PM, Kallas EG, de Souza RF, Holmes EC: Genealogical evidence for positive selection in the nef gene of HIV-1. Genetics 1999, 153: 1077-1089.PubMedCentralPubMed
10.
go back to reference Kosakovsky Pond S, Muse SV: Site-to-site variation of synonymous substitution rates. Mol Biol Evol 2005, 22: 2375-2385. 10.1093/molbev/msi232CrossRef Kosakovsky Pond S, Muse SV: Site-to-site variation of synonymous substitution rates. Mol Biol Evol 2005, 22: 2375-2385. 10.1093/molbev/msi232CrossRef
11.
go back to reference Hurst LD, Pal C: Evidence for purifying selection acting on silent sites in BRCA1 . TRENDS in Genetics 2001, 17: 62-65. 10.1016/S0168-9525(00)02173-9CrossRefPubMed Hurst LD, Pal C: Evidence for purifying selection acting on silent sites in BRCA1 . TRENDS in Genetics 2001, 17: 62-65. 10.1016/S0168-9525(00)02173-9CrossRefPubMed
12.
go back to reference Quinones-Mateu ME, Mas A, Lain dL, Soriano V, Alcami J, Lederman MM, Domingo E: LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Res 1998, 57: 11-20. 10.1016/S0168-1702(98)00082-3CrossRefPubMed Quinones-Mateu ME, Mas A, Lain dL, Soriano V, Alcami J, Lederman MM, Domingo E: LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Res 1998, 57: 11-20. 10.1016/S0168-1702(98)00082-3CrossRefPubMed
13.
go back to reference Das AT, Klaver B, Berkhout B: The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol 1998, 72: 9217-9223.PubMedCentralPubMed Das AT, Klaver B, Berkhout B: The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol 1998, 72: 9217-9223.PubMedCentralPubMed
14.
go back to reference Wilkinson KA, Gorelick RJ, Vasa SM, Guex N, Rein A, Mathews DH, Giddings MC, Weeks KM: High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol 2008, 6: e96. 10.1371/journal.pbio.0060096PubMedCentralCrossRefPubMed Wilkinson KA, Gorelick RJ, Vasa SM, Guex N, Rein A, Mathews DH, Giddings MC, Weeks KM: High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol 2008, 6: e96. 10.1371/journal.pbio.0060096PubMedCentralCrossRefPubMed
15.
go back to reference Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ: A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 2000, 28: 663-668. 10.1093/nar/28.3.663PubMedCentralCrossRefPubMed Pereira LA, Bentley K, Peeters A, Churchill MJ, Deacon NJ: A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 2000, 28: 663-668. 10.1093/nar/28.3.663PubMedCentralCrossRefPubMed
16.
go back to reference Goffin V, Demonte D, Vanhulle C, de Walque S, de Launoit Y, Burny A, Collette Y, Van Lint C: Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity. Nucleic Acids Res 2005, 33: 4285-4310. 10.1093/nar/gki720PubMedCentralCrossRefPubMed Goffin V, Demonte D, Vanhulle C, de Walque S, de Launoit Y, Burny A, Collette Y, Van Lint C: Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity. Nucleic Acids Res 2005, 33: 4285-4310. 10.1093/nar/gki720PubMedCentralCrossRefPubMed
17.
go back to reference Van Lint C, Ghysdael J, Paras P Jr, Burny A, Verdin E: A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol 1994, 68: 2632-2648.PubMedCentralPubMed Van Lint C, Ghysdael J, Paras P Jr, Burny A, Verdin E: A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol 1994, 68: 2632-2648.PubMedCentralPubMed
18.
go back to reference Verdin E, Becker N, Bex F, Droogmans L, Burny A: Identification and characterization of an enhancer in the coding region of the genome of human immunodeficiency virus type 1. Proc Natl Acad Sci 1990, 87: 4874-4878. 10.1073/pnas.87.12.4874PubMedCentralCrossRefPubMed Verdin E, Becker N, Bex F, Droogmans L, Burny A: Identification and characterization of an enhancer in the coding region of the genome of human immunodeficiency virus type 1. Proc Natl Acad Sci 1990, 87: 4874-4878. 10.1073/pnas.87.12.4874PubMedCentralCrossRefPubMed
19.
go back to reference Hadzopoulou-Cladaras M, Felber BK, Cladaras C, Athanassopoulos A, Tse A, Pavlakis GN: The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J Virol 1989, 63: 1265-1274.PubMedCentralPubMed Hadzopoulou-Cladaras M, Felber BK, Cladaras C, Athanassopoulos A, Tse A, Pavlakis GN: The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J Virol 1989, 63: 1265-1274.PubMedCentralPubMed
20.
go back to reference Renwick SB, Critchley AD, Adams CJ, Kelly SM, Price NC, Stockley PG: Probing the details of the HIV-1 Rev-Rev-responsive element interaction: effects of modified nucleotides on protein affinity and conformational changes during complex formation. Biochem J 1995,308(Pt 2):447-453.PubMedCentralCrossRefPubMed Renwick SB, Critchley AD, Adams CJ, Kelly SM, Price NC, Stockley PG: Probing the details of the HIV-1 Rev-Rev-responsive element interaction: effects of modified nucleotides on protein affinity and conformational changes during complex formation. Biochem J 1995,308(Pt 2):447-453.PubMedCentralCrossRefPubMed
21.
go back to reference Peterson RD, Feigon J: Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide. J Mol Biol 1996, 264: 863-877. 10.1006/jmbi.1996.0683CrossRefPubMed Peterson RD, Feigon J: Structural change in Rev responsive element RNA of HIV-1 on binding Rev peptide. J Mol Biol 1996, 264: 863-877. 10.1006/jmbi.1996.0683CrossRefPubMed
22.
go back to reference Phuphuakrat A, Auewarakul P: Heterogeneity of HIV-1 Rev response element. AIDS Res Hum Retroviruses 2003, 19: 569-574. 10.1089/088922203322230932CrossRefPubMed Phuphuakrat A, Auewarakul P: Heterogeneity of HIV-1 Rev response element. AIDS Res Hum Retroviruses 2003, 19: 569-574. 10.1089/088922203322230932CrossRefPubMed
23.
go back to reference Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber BK, Pavlakis GN: Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol 1992, 66: 7176-7182.PubMedCentralPubMed Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber BK, Pavlakis GN: Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J Virol 1992, 66: 7176-7182.PubMedCentralPubMed
24.
go back to reference Schneider R, Campbell M, Nasioulas G, Felber BK, Pavlakis GN: Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J Virol 1997, 71: 4892-4903.PubMedCentralPubMed Schneider R, Campbell M, Nasioulas G, Felber BK, Pavlakis GN: Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J Virol 1997, 71: 4892-4903.PubMedCentralPubMed
25.
go back to reference Cochrane AW, Jones KS, Beidas S, Dillon PJ, Skalka AM, Rosen CA: Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol 1991, 65: 5305-5313.PubMedCentralPubMed Cochrane AW, Jones KS, Beidas S, Dillon PJ, Skalka AM, Rosen CA: Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol 1991, 65: 5305-5313.PubMedCentralPubMed
26.
go back to reference Wolff H, Brack-Werner R, Neumann M, Werner T, Schneider R: Intergrated functional and bioinformatics approach for the identification and experimental verification of RNA signals: application to HIV-1 INS. Nucleic Acids Research 2003, 31: 2839-2851. 10.1093/nar/gkg390PubMedCentralCrossRefPubMed Wolff H, Brack-Werner R, Neumann M, Werner T, Schneider R: Intergrated functional and bioinformatics approach for the identification and experimental verification of RNA signals: application to HIV-1 INS. Nucleic Acids Research 2003, 31: 2839-2851. 10.1093/nar/gkg390PubMedCentralCrossRefPubMed
27.
go back to reference Anisimova M, Nielsen R, Yang Z: Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. Genetics 2003, 164: 1229-1236.PubMedCentralPubMed Anisimova M, Nielsen R, Yang Z: Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. Genetics 2003, 164: 1229-1236.PubMedCentralPubMed
28.
go back to reference Shriner D, Nickle DC, Jensen MA, Mullins JI: Potential impact of recombination on sitewise approaches for detecting positive natural selection. Genet Res 2003, 81: 115-121. 10.1017/S0016672303006128CrossRefPubMed Shriner D, Nickle DC, Jensen MA, Mullins JI: Potential impact of recombination on sitewise approaches for detecting positive natural selection. Genet Res 2003, 81: 115-121. 10.1017/S0016672303006128CrossRefPubMed
29.
go back to reference Leitner T, Foley B, Hahn B, Marx P, McCutchan F, Mellors J, Wolinsky S, Korber B: HIV Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, LA-UR 2005, 06-0680. Leitner T, Foley B, Hahn B, Marx P, McCutchan F, Mellors J, Wolinsky S, Korber B: HIV Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, LA-UR 2005, 06-0680.
30.
go back to reference Kosakovsky Pond SL, Frost SD, Muse SV: HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21: 676-679. 10.1093/bioinformatics/bti079CrossRef Kosakovsky Pond SL, Frost SD, Muse SV: HyPhy: hypothesis testing using phylogenies. Bioinformatics 2005, 21: 676-679. 10.1093/bioinformatics/bti079CrossRef
31.
go back to reference Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost S: Automated Phylogenetic Detection of Recombination Using a Genetic Algorithm. Mol Biol Evol 2006, 23: 1891-1901. 10.1093/molbev/msl051CrossRefPubMed Kosakovsky Pond SL, Posada D, Gravenor MB, Woelk CH, Frost S: Automated Phylogenetic Detection of Recombination Using a Genetic Algorithm. Mol Biol Evol 2006, 23: 1891-1901. 10.1093/molbev/msl051CrossRefPubMed
32.
go back to reference Scheffler K, Martin DP, Seoighe C: Robust inference of positive selection from recombining coding sequences. Bioinformatics 2006, 22: 2493-2499. 10.1093/bioinformatics/btl427CrossRefPubMed Scheffler K, Martin DP, Seoighe C: Robust inference of positive selection from recombining coding sequences. Bioinformatics 2006, 22: 2493-2499. 10.1093/bioinformatics/btl427CrossRefPubMed
33.
go back to reference Ngandu NG, Bredell H, Gray CM, Williamson C, Seoighe C: CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs. AIDS Res Hum Retroviruses 2007, 23: 1033-1041. 10.1089/aid.2007.0024CrossRefPubMed Ngandu NG, Bredell H, Gray CM, Williamson C, Seoighe C: CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs. AIDS Res Hum Retroviruses 2007, 23: 1033-1041. 10.1089/aid.2007.0024CrossRefPubMed
34.
go back to reference Yang Z, Wong WS, Nielsen R: Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol 2005, 22: 1107-1118. 10.1093/molbev/msi097CrossRefPubMed Yang Z, Wong WS, Nielsen R: Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol 2005, 22: 1107-1118. 10.1093/molbev/msi097CrossRefPubMed
35.
go back to reference Moore PL, Gray ES, Choge IA, Ranchobe N, Mlisana K, Abdool Karim SS, Williamson C, Morris L: The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J Virol 2008, 82: 1860-1869. 10.1128/JVI.02187-07PubMedCentralCrossRefPubMed Moore PL, Gray ES, Choge IA, Ranchobe N, Mlisana K, Abdool Karim SS, Williamson C, Morris L: The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection. J Virol 2008, 82: 1860-1869. 10.1128/JVI.02187-07PubMedCentralCrossRefPubMed
36.
go back to reference Clever J, Sassetti C, Parslow TG: RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1. J Virol 1995, 69: 2101-2109.PubMedCentralPubMed Clever J, Sassetti C, Parslow TG: RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1. J Virol 1995, 69: 2101-2109.PubMedCentralPubMed
37.
go back to reference Huthoff H, Das AT, Vink M, Klaver B, Zorgdrager F, Cornelissen M, Berkhout B: A human immunodeficiency virus type 1-infected individual with low viral load harbors a virus variant that exhibits an in vitro RNA dimerization defect. J Virol 2004, 78: 4907-4913. 10.1128/JVI.78.9.4907-4913.2004PubMedCentralCrossRefPubMed Huthoff H, Das AT, Vink M, Klaver B, Zorgdrager F, Cornelissen M, Berkhout B: A human immunodeficiency virus type 1-infected individual with low viral load harbors a virus variant that exhibits an in vitro RNA dimerization defect. J Virol 2004, 78: 4907-4913. 10.1128/JVI.78.9.4907-4913.2004PubMedCentralCrossRefPubMed
38.
go back to reference Exline CM, Feng Z, Stoltzfus CM: Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression. J Virol 2008, 82: 3921-3931. 10.1128/JVI.01558-07PubMedCentralCrossRefPubMed Exline CM, Feng Z, Stoltzfus CM: Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression. J Virol 2008, 82: 3921-3931. 10.1128/JVI.01558-07PubMedCentralCrossRefPubMed
39.
go back to reference Schwartz S, Felber BK, Benko DM, Fenyo EM, Pavlakis GN: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 1990, 64: 2519-2529.PubMedCentralPubMed Schwartz S, Felber BK, Benko DM, Fenyo EM, Pavlakis GN: Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 1990, 64: 2519-2529.PubMedCentralPubMed
40.
go back to reference Madsen JM, Stoltzfus CM: A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication. Retrovirology 2006, 3: 10. 10.1186/1742-4690-3-10PubMedCentralCrossRefPubMed Madsen JM, Stoltzfus CM: A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication. Retrovirology 2006, 3: 10. 10.1186/1742-4690-3-10PubMedCentralCrossRefPubMed
41.
go back to reference Kammler S, Otte M, Hauber I, Kjems J, Hauber J, Schaal H: The strength of the HIV-1 3' splice sites affects Rev function. Retrovirology 2006, 3: 89. 10.1186/1742-4690-3-89PubMedCentralCrossRefPubMed Kammler S, Otte M, Hauber I, Kjems J, Hauber J, Schaal H: The strength of the HIV-1 3' splice sites affects Rev function. Retrovirology 2006, 3: 89. 10.1186/1742-4690-3-89PubMedCentralCrossRefPubMed
42.
go back to reference Krummheuer J, Lenz C, Kammler S, Scheid A, Schaal H: Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression. Virology 2001, 286: 276-289. 10.1006/viro.2001.0974CrossRefPubMed Krummheuer J, Lenz C, Kammler S, Scheid A, Schaal H: Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression. Virology 2001, 286: 276-289. 10.1006/viro.2001.0974CrossRefPubMed
43.
go back to reference Jacquenet S, Mereau A, Bilodeau PS, Damier L, Stoltzfus CM, Branlant C: A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J Biol Chem 2001, 276: 40464-40475. 10.1074/jbc.M104070200CrossRefPubMed Jacquenet S, Mereau A, Bilodeau PS, Damier L, Stoltzfus CM, Branlant C: A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. J Biol Chem 2001, 276: 40464-40475. 10.1074/jbc.M104070200CrossRefPubMed
44.
go back to reference Jacquenet S, Ropers D, Bilodeau PS, Damier L, Mougin A, Stoltzfus CM, Branlant C: Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing. Nucleic Acids Res 2001, 29: 464-478. 10.1093/nar/29.2.464PubMedCentralCrossRefPubMed Jacquenet S, Ropers D, Bilodeau PS, Damier L, Mougin A, Stoltzfus CM, Branlant C: Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing. Nucleic Acids Res 2001, 29: 464-478. 10.1093/nar/29.2.464PubMedCentralCrossRefPubMed
45.
go back to reference Hung LW, Holbrook EL, Holbrook SR: The crystal structure of the Rev binding element of HIV-1 reveals novel base pairing and conformational variability. Proc Natl Acad Sci USA 2000, 97: 5107-5112. 10.1073/pnas.090588197PubMedCentralCrossRefPubMed Hung LW, Holbrook EL, Holbrook SR: The crystal structure of the Rev binding element of HIV-1 reveals novel base pairing and conformational variability. Proc Natl Acad Sci USA 2000, 97: 5107-5112. 10.1073/pnas.090588197PubMedCentralCrossRefPubMed
46.
go back to reference Schwartz S, Felber BK, Fenyo EM, Pavlakis GN: Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol 1990, 64: 5448-5456.PubMedCentralPubMed Schwartz S, Felber BK, Fenyo EM, Pavlakis GN: Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J Virol 1990, 64: 5448-5456.PubMedCentralPubMed
47.
go back to reference Swanson AK, Stoltzfus CM: Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs. J Biol Chem 1998, 273: 34551-34557. 10.1074/jbc.273.51.34551CrossRefPubMed Swanson AK, Stoltzfus CM: Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs. J Biol Chem 1998, 273: 34551-34557. 10.1074/jbc.273.51.34551CrossRefPubMed
48.
go back to reference Miles LR, Agresta BE, Khan MB, Tang S, Levin JG, Powell MD: Effect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity. J Virol 2005, 79: 6859-6867. 10.1128/JVI.79.11.6859-6867.2005PubMedCentralCrossRefPubMed Miles LR, Agresta BE, Khan MB, Tang S, Levin JG, Powell MD: Effect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity. J Virol 2005, 79: 6859-6867. 10.1128/JVI.79.11.6859-6867.2005PubMedCentralCrossRefPubMed
49.
go back to reference Luo GX, Sharmeen L, Taylor J: Specificities involved in the initiation of retroviral plus-strand DNA. J Virol 1990, 64: 592-597.PubMedCentralPubMed Luo GX, Sharmeen L, Taylor J: Specificities involved in the initiation of retroviral plus-strand DNA. J Virol 1990, 64: 592-597.PubMedCentralPubMed
50.
go back to reference Rausch JW, Le Grice SF: Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis. Nucleic Acids Res 2007, 35: 256-268. 10.1093/nar/gkl909PubMedCentralCrossRefPubMed Rausch JW, Le Grice SF: Purine analog substitution of the HIV-1 polypurine tract primer defines regions controlling initiation of plus-strand DNA synthesis. Nucleic Acids Res 2007, 35: 256-268. 10.1093/nar/gkl909PubMedCentralCrossRefPubMed
51.
go back to reference Powell MD, Levin JG: Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract. J Virol 1996, 70: 5288-5296.PubMedCentralPubMed Powell MD, Levin JG: Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract. J Virol 1996, 70: 5288-5296.PubMedCentralPubMed
52.
go back to reference Pullen KA, Rattray AJ, Champoux JJ: The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem 1993, 268: 6221-6227.PubMed Pullen KA, Rattray AJ, Champoux JJ: The sequence features important for plus strand priming by human immunodeficiency virus type 1 reverse transcriptase. J Biol Chem 1993, 268: 6221-6227.PubMed
53.
go back to reference Rausch JW, Le Grice SF: 'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int J Biochem Cell Biol 2004, 36: 1752-1766. 10.1016/j.biocel.2004.02.016CrossRefPubMed Rausch JW, Le Grice SF: 'Binding, bending and bonding': polypurine tract-primed initiation of plus-strand DNA synthesis in human immunodeficiency virus. Int J Biochem Cell Biol 2004, 36: 1752-1766. 10.1016/j.biocel.2004.02.016CrossRefPubMed
54.
go back to reference Masuda T, Kuroda MJ, Harada S: Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo. J Virol 1998, 72: 8396-8402.PubMedCentralPubMed Masuda T, Kuroda MJ, Harada S: Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo. J Virol 1998, 72: 8396-8402.PubMedCentralPubMed
55.
go back to reference Brown HE, Chen H, Engelman A: Structure-based mutagenesis of the human immunodeficiency virus type 1 DNA attachment site: effects on integration and cDNA synthesis. J Virol 1999, 73: 9011-9020.PubMedCentralPubMed Brown HE, Chen H, Engelman A: Structure-based mutagenesis of the human immunodeficiency virus type 1 DNA attachment site: effects on integration and cDNA synthesis. J Virol 1999, 73: 9011-9020.PubMedCentralPubMed
56.
go back to reference Rose PP, Korber BT: Detecting hypermutations in viral sequences with an emphasis on G --> A hypermutation. Bioinformatics 2000, 16: 400-401. 10.1093/bioinformatics/16.4.400CrossRefPubMed Rose PP, Korber BT: Detecting hypermutations in viral sequences with an emphasis on G --> A hypermutation. Bioinformatics 2000, 16: 400-401. 10.1093/bioinformatics/16.4.400CrossRefPubMed
57.
go back to reference Hanada K, Suzuki Y, Gojobori T: A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol Biol Evol 2004, 21: 1074-1080. 10.1093/molbev/msh109CrossRefPubMed Hanada K, Suzuki Y, Gojobori T: A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol Biol Evol 2004, 21: 1074-1080. 10.1093/molbev/msh109CrossRefPubMed
58.
go back to reference Paillart JC, Skripkin E, Ehresmann B, Ehresmann C, Marquet R: In vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNA. J Biol Chem 2002, 277: 5995-6004. 10.1074/jbc.M108972200CrossRefPubMed Paillart JC, Skripkin E, Ehresmann B, Ehresmann C, Marquet R: In vitro evidence for a long range pseudoknot in the 5'-untranslated and matrix coding regions of HIV-1 genomic RNA. J Biol Chem 2002, 277: 5995-6004. 10.1074/jbc.M108972200CrossRefPubMed
59.
go back to reference Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E: MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 2003, 31: 3576-3579. 10.1093/nar/gkg585PubMedCentralCrossRefPubMed Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, Wingender E: MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res 2003, 31: 3576-3579. 10.1093/nar/gkg585PubMedCentralCrossRefPubMed
60.
go back to reference Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Munch R, Reuter I, Rotert S, Saxel H, Scheer M, Thiele S, Wingender E: TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 2003, 31: 374-378. 10.1093/nar/gkg108PubMedCentralCrossRefPubMed Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE, Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Munch R, Reuter I, Rotert S, Saxel H, Scheer M, Thiele S, Wingender E: TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 2003, 31: 374-378. 10.1093/nar/gkg108PubMedCentralCrossRefPubMed
Metadata
Title
Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences
Authors
Nobubelo K Ngandu
Konrad Scheffler
Penny Moore
Zenda Woodman
Darren Martin
Cathal Seoighe
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2008
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-5-160

Other articles of this Issue 1/2008

Virology Journal 1/2008 Go to the issue